{"id":"https://openalex.org/W4381892477","doi":"https://doi.org/10.3389/fimmu.2023.1227231","title":"Editorial: Immunogenicity and toxicity of AAV gene therapy","display_name":"Editorial: Immunogenicity and toxicity of AAV gene therapy","alternate_titles":[],"publication_year":2023,"publication_date":"2023-06-22","ids":{"openalex":"https://openalex.org/W4381892477","doi":"https://doi.org/10.3389/fimmu.2023.1227231","pmid":"https://pubmed.ncbi.nlm.nih.gov/37426652","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10325706"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2023.1227231","doi":"https://doi.org/10.3389/fimmu.2023.1227231","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2023.1227231","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227231/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4381892477"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227231/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024450225","display_name":"Allison M. Bradbury","orcid":"https://orcid.org/0000-0002-8268-3743","observed_orcids":["https://orcid.org/0000-0002-8268-3743"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I4405283103","display_name":"Abigail Wexner Research Institute","ror":"https://ror.org/010dtsm51","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1314135232","https://openalex.org/I4405283103"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Allison Bradbury","raw_affiliation_strings":["Center for Gene Therapy, Abigail Wexner Research Institute Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Gene Therapy, Abigail Wexner Research Institute Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, United States","institution_ids":["https://openalex.org/I1314135232","https://openalex.org/I4405283103","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008445793","display_name":"David M. Markusic","orcid":"https://orcid.org/0000-0002-3774-0825","observed_orcids":["https://orcid.org/0000-0002-3774-0825"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Markusic","raw_affiliation_strings":["Department of Pediatrics, Indiana University, Indianapolis, IN, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Indiana University, Indianapolis, IN, United States","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067369102","display_name":"Manish Muhuri","orcid":"https://orcid.org/0000-0003-3265-903X","observed_orcids":["https://orcid.org/0000-0003-3265-903X"]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Manish Muhuri","raw_affiliation_strings":["Horae Gene Therapy Center, Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Horae Gene Therapy Center, Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, United States","institution_ids":["https://openalex.org/I166722992"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100705339","display_name":"Li Ou","orcid":"https://orcid.org/0000-0002-7743-5649","observed_orcids":["https://orcid.org/0000-0002-7743-5649"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Li Ou","raw_affiliation_strings":["Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States","Department of Research & Discovery, Genemagic Biosciences, Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Department of Research & Discovery, Genemagic Biosciences, Philadelphia, PA, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5008445793","https://openalex.org/A5024450225","https://openalex.org/A5067369102","https://openalex.org/A5100705339"],"corresponding_institution_ids":["https://openalex.org/I130238516","https://openalex.org/I1314135232","https://openalex.org/I166722992","https://openalex.org/I4388446366","https://openalex.org/I4405283103","https://openalex.org/I52357470"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":null,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":null,"first_page":"1227231","last_page":"1227231"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-adeno-associated-virus","display_name":"recombinant adeno-associated virus","score":0.8970000147819519},{"id":"https://openalex.org/keywords/aav-gene-therapy","display_name":"AAV gene therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8190000057220459},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8220000267028809},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.8059999942779541},{"id":"https://openalex.org/keywords/aav-serotypes","display_name":"AAV serotypes","score":0.75},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.6349999904632568},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.8679999709129333},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.7289999723434448},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8379999995231628},{"id":"https://openalex.org/keywords/c3-inhibitor","display_name":"C3 inhibitor","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8994220495223999},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5525727272033691},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5312060713768005},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4527492821216583},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4523022770881653},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.38140588998794556},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3319249749183655},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32726526260375977},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32417625188827515},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2559465169906616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18148592114448547},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1467839479446411},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1335446834564209}],"mesh":[{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018014","descriptor_name":"Gene Transfer Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2023.1227231","doi":"https://doi.org/10.3389/fimmu.2023.1227231","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2023.1227231","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227231/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10325706","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10325706","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10325706/pdf/fimmu-14-1227231.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:37426652","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37426652","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:9129405587204301845423767510bad4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9129405587204301845423767510bad4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 14 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2023.1227231","doi":"https://doi.org/10.3389/fimmu.2023.1227231","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2023.1227231","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227231/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4381892477.pdf","grobid_xml":"https://content.openalex.org/works/W4381892477.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4307633692","https://openalex.org/W7147577727","https://openalex.org/W4322758747","https://openalex.org/W4291164838","https://openalex.org/W4293223872","https://openalex.org/W4386470312","https://openalex.org/W4294219141","https://openalex.org/W2336475925","https://openalex.org/W1994064996","https://openalex.org/W7211962090"],"abstract_inverted_index":{"Editorial":[0],"on":[1,144,213],"the":[2,36,51,57,131,145,184,206,284],"Research":[3],"Topic":[4],"Immunogenicity":[5],"and":[6,25,32,72,117,138,156,178,204,274,302,312,315],"toxicity":[7,74],"of":[8,62,82,89,110,125,136,163,175,189,196,219,236,247,286,308],"AAV":[9,52,115,127,197,237,250,278,287,320],"gene":[10,23,42,214],"therapyRecombinant":[11],"adeno-associated":[12],"virus":[13],"(AAV)":[14],"is":[15,99],"a":[16,60,107,123,193,244,326],"promising":[17],"delivery":[18,235],"vehicle":[19],"for":[20,41,102,153],"in":[21,30,84,232,249,267,293],"vivo":[22],"therapy":[24,215],"has":[26],"been":[27,48,76],"widely":[28],"tested":[29],"preclinical":[31],"clinical":[33,86,128],"studies.However,":[34],"despite":[35],"vast":[37],"promise":[38],"they":[39],"hold":[40],"therapy,":[43],"debilitating":[44],"immune":[45,295,316],"responses":[46],"have":[47,75,224,241],"reported":[49],"against":[50],"capsid":[53],"itself":[54],"and/or":[55],"to":[56,80,228,305],"transgene":[58],"product.As":[59],"result":[61],"high":[63,277],"vector":[64,207],"doses,":[65],"serious":[66,166],"adverse":[67,91,167,220],"effects":[68],"like":[69],"complement":[70,248,313],"activation":[71,318],"liver":[73],"observed,":[77],"even":[78],"leading":[79,304],"fatality":[81],"subjects":[83],"certain":[85],"trials.Although":[87],"many":[88],"these":[90],"events":[92,168],"can":[93],"be":[94],"managed":[95],"with":[96,147,180,325],"immunosuppressants,":[97],"this":[98,259],"not":[100,242],"true":[101],"all":[103],"trial":[104],"participants.To":[105],"gain":[106],"better":[108],"understanding":[109],"factors":[111],"that":[112,205,276],"may":[113],"influence":[114],"immunity":[116],"durability,":[118],"Shen":[119],"et":[120,263],"al.":[121,264],"conducted":[122,265],"meta-analysis":[124],"255":[126],"trials":[129,152,203],"over":[130],"past":[132],"25":[133],"years.The":[134],"usage":[135],"immunosuppressants":[137],"antibody":[139,199,280],"screening":[140],"assays":[141],"highly":[142],"depended":[143],"indications,":[146],"relatively":[148],"lower":[149],"frequency":[150,218],"among":[151],"treating":[154],"retinal":[155],"central":[157],"nervous":[158],"system":[159],"(CNS)":[160],"diseases.The":[161],"rates":[162],"treatment":[164],"emergent":[165],"(TESAEs)":[169],"also":[170],"varied":[171],"by":[172,319],"indication,":[173],"routes":[174],"administration,":[176],"serotype,":[177],"dosage,":[179],"CNS":[181],"diseases":[182],"having":[183],"highest":[185],"risk.Other":[186],"interesting":[187],"findings":[188],"their":[190],"analysis":[191],"include":[192],"broad":[194],"range":[195],"neutralizing":[198,279],"titer":[200],"cutoffs":[201],"between":[202],"production":[208,307],"platform":[209],"had":[210],"no":[211],"impact":[212],"durability":[216],"or":[217,291],"events.Recently,":[221],"complement-mediated":[222],"AEs":[223],"emerged":[225],"as":[226],"contributing":[227],"immunemediated":[229],"toxicities,":[230,252],"specifically":[231],"high-dose":[233],"systemic":[234],"vectors.Because":[238],"animal":[239],"models":[240],"shown":[243],"direct":[245],"role":[246],"mediated":[251],"detailed":[253],"mechanistic":[254],"studies":[255,266],"are":[256],"lacking.To":[257],"address":[258],"knowledge":[260],"gap,":[261],"Smith":[262],"human":[268],"PBMCs":[269],"obtained":[270],"from":[271],"multiple":[272],"donors":[273],"found":[275],"titers":[281],">1:100":[282],"enhanced":[283],"uptake":[285],"viral":[288],"particles":[289],"(empty":[290],"full)":[292],"several":[294],"cells":[296],"including":[297],"neutrophils,":[298],"monocyte-related":[299],"dendritic":[300],"cells,":[301],"monocytes":[303],"increased":[306],"pro-inflammatory":[309],"cytokines/":[310],"chemokines":[311],"activation.Uptake":[314],"cell":[317],"vectors":[321],"were":[322],"significantly":[323],"reduced":[324],"C3":[327],"inhibitor,":[328],"APL-9.":[329]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4381892477","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-06-25T00:00:00"}
